Skip to content

Drug interactions

Sipuleucel-t + Tocilizumab

Severity: Moderate

Sipuleucel-t and Tocilizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sipuleucel-T relies on the patient's own immune cells being activated against prostate cancer antigen. Immunosuppressive drugs such as tocilizumab could reduce this response and the benefit of the treatment.

What this interaction means in plain words

Sipuleucel-t and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Immunosuppression from interleukin-6 blockade may blunt the immune activation that sipuleucel-T depends on; this is predicted rather than well studied.

What to do

Avoid immunosuppressive therapy around the leukapheresis and infusion period where possible. If tocilizumab is needed, discuss the likely reduced efficacy with the oncology team.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sipuleucel-t and Tocilizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sipuleucel-t with Tocilizumab?

MediHelp rates the interaction as moderate. Sipuleucel-t and Tocilizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T relies on the patient's own immune cells being activated against prostate cancer antigen. Immunosuppressive drugs such as tocilizumab could reduce this response and the benefit of the treatment.

How serious is the interaction between Sipuleucel-t and Tocilizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid immunosuppressive therapy around the leukapheresis and infusion period where possible. If tocilizumab is needed, discuss the likely reduced efficacy with the oncology team.

What other medicines interact with Tocilizumab?

MediHelp also lists interactions of Tocilizumab with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Tocilizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in